Kobayashi Misato, Ohno Tamio, Kawada Teruo, Ikegami Hiroshi, Nishimura Masahiko, Horio Fumihiko
Department of Applied Molecular Bioscience, Graduate School of Bioagricultural Sciences, Nagoya University, Nagoya, Japan.
Biosci Biotechnol Biochem. 2006 Mar;70(3):677-83. doi: 10.1271/bbb.70.677.
Adiponectin is thought to be an important mediator of insulin sensitivity and atherosclerosis. Using mouse 19 SMXA recombinant inbred (RI) strains, a powerful tool for analyzing multifactorial genetic traits, we found relationships between serum adiponectin levels and diabetes-related traits, body mass index, and serum lipid levels, and also determined the loci controlling serum adiponectin levels by quantitative trait loci (QTL) analysis. RI strains exhibited widely ranging serum adiponectin concentration distribution patterns and diabetes-related traits. The serum adiponectin concentration showed the strongest negative correlation with fasting serum insulin concentration, but negative correlations were also observed with serum triglycerides, cholesterol, and liver weight. In contrast, neither the body mass index nor the blood glucose concentration correlated with serum adiponectin levels. These results suggest that hypoadiponectinemia might be used as a predictor of insulin resistance. In addition, two suggestive QTLs for serum adiponectin concentration were detected on Chromosome (Chr) 7, and an A/J allele at these loci was associated with elevated serum adiponectin concentrations. Identification of genes responsible for regulating the serum adiponectin concentration might lead to the development of novel treatments for patients with diabetes concomitant with hypoadiponectinemia.
脂联素被认为是胰岛素敏感性和动脉粥样硬化的重要介质。利用小鼠19个SMXA重组近交(RI)品系(一种分析多因素遗传性状的强大工具),我们发现血清脂联素水平与糖尿病相关性状、体重指数和血脂水平之间存在关联,并且通过数量性状基因座(QTL)分析确定了控制血清脂联素水平的基因座。RI品系呈现出广泛的血清脂联素浓度分布模式和糖尿病相关性状。血清脂联素浓度与空腹血清胰岛素浓度呈现出最强的负相关,但与血清甘油三酯、胆固醇和肝脏重量也存在负相关。相比之下,体重指数和血糖浓度均与血清脂联素水平无相关性。这些结果表明,低脂联素血症可能用作胰岛素抵抗的预测指标。此外,在第7号染色体(Chr)上检测到两个提示性的血清脂联素浓度QTL,这些基因座上的A/J等位基因与血清脂联素浓度升高相关。鉴定负责调节血清脂联素浓度的基因可能会为伴有低脂联素血症的糖尿病患者开发新的治疗方法。